A fight over the future of cancer care is playing out in a behind-the-scenes battle over Dana-Farber Cancer Institute’s ...

In response to Trump science policies, universities are accepting fewer graduate students than normal and freezing positions, ...

Lecanemab has given us more years together. That’s not ‘minute’ nor ‘minimal’ to me,” writes one reader in STAT’s letters to ...

Dr. Oz's assets range from a tree trimming company to a cattle farm to UnitedHealth stock, and they're worth up to $334 ...

The Maryland House of Delegates has voted overwhelmingly to allow a state board to extend its mandate for lowering ...

Words such as “health equity” are being replacing with vaguer terms, and 100 members sent a letter of protest to NASEM ...

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we ...

Disabled workers on a two-year probation were especially vulnerable during the Trump administration's mass firings.

Judge Angel Kelley kept in place an order blocking the Trump administration from implementing a 15% cap on NIH indirect cost ...

Catch up on the biggest news and takeaways from AACR Annual Meeting 2025 — one of the most important gatherings in oncology.

The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for ...